chartexchange

ENLV
Enlivex Ltd.
stockNASDAQ

At CloseNov 17, 2026 3:59:30 PM EST
1.17USD+4.464%(+0.05)18,949
After-hoursNov 17, 2026 4:00:30 PM EST
1.15USD-1.709%(-0.02)
1.0000Bid1.3300Ask0.3300Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Ness Ziona, Ness Ziona, Israel
Previous Close
$1.12
Beta
6.68
52-Week High
$27.15 2025-11-24
52-Week Low
$0.17 2026-10-23
SMA 50
$0.88
SMA 200
$7.97
Avg. Vol 10D
34,560
Avg. Vol 30D
1.56M
Avg. Vol 90D
785,933
Relative Vol
0.01
16.75M
1093.15%
98.6200%
1,506
Jul 9, 2026 · 1-for-15 (reverse)
ENLV Profile

enlivex therapeutics ltd., a clinical stage immunotherapy company, engages in developing allogeneic drugs for immune system rebalancing. its product candidate is allocetra, an immunotherapy candidate, which is in phase iib clinical trial in patients with severe sepsis; that is in investigator-initiated phase ii clinical trial for the treatment of covid-19 patients in severe and critical conditions; and which is in phase iia clinical trial for the prevention of graft versus host disease in allogeneic hematopoietic stem cell transplants (hsct) patients. the company is also developing allocetra for the prevention of complications associated with bone marrow transplantations and/or hsct, and acute multiple organ failure. it also intends to develop its cell-based therapy to be combined with treatments of solid tumors via immune checkpoint rebalancing to enhance the efficacy of various anti-cancer therapies, including chimeric antigen receptor t-cell therapy and therapies targeting t-cell re

ENLV Performance
PeriodPriceDateChangeBeta
1W1.202026-11-10-2.50%3.397
1M0.212026-10-16+470.73%33.033
3M1.582026-08-17-25.95%21.588
6M10.462026-05-18-88.81%11.330
1Y14.632025-11-17-92.00%6.677
2Y15.752024-11-18-92.57%—
5Y127.952021-11-17-99.09%1.497
ENLV Stock Summary

Enlivex Ltd. (NASDAQ:ENLV) stock price today is $1.17, and today's volume is 18,301. ENLV is up 4.464% today. The 30 day average volume is 1.56M. ENLV market cap is $1.79M with 1.53M shares outstanding.